IL10 and COVID-19: Studies have indicated that patients with severe COVID-19 exhibit elevated levels of pro-inflammatory cytokines (IL-6, tumor necrosis factor-α) and anti-inflammatory cytokines (IL-4, IL-10), along with decreased expression of CD4 and CD8 cells (Chen et al., 2020; Tay et al., 2020).